Definitive Contract 75F40122C00107
- Not listed
- This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
- This is a $1,558,251.00 Firm Fixed Price federal contract awarded by the Food and Drug Administration (FDA) to the Missouri Department of Health & Senior Services (MDHSS). The contract is for the MISSOURI MQSA INSPECTION CONTRACT, which involves MDHSS conducting inspections of certified non-federal mammography facilities in Missouri to ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract was awarded on a sole source basis, as state...
- This is a $2,685,565.01 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH) for Massachusetts MQSA (Mammography Quality Standards Act) new contract services. The contract has no set-aside designation and an ultimate completion date of January 21, 2028. MDPH, a U.S. state government agency, is the prime contractor and will provide specialized public health services to the FDA, including food and tobacco...
- This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the Massachusetts Department of Public Health, a U.S. state government entity, for Mass MQSA (Mammography Quality Standards Act) inspections. The contract has a firm fixed price pricing type and a potential value of $1,711,136.29. It was awarded on June 1, 2017 with a completion date of June 30, 2022. This contract is not associated with a larger vehicle and does not have a...
- This is a definitive, firm-fixed-price federal contract award for $13,120,419.42 to the California Department of Public Health (CDPH), a division of the State of California Controllers Office, by the Food and Drug Administration (FDA). The contract is for the Mammography Quality Standards Act (MQSA) Program, a civilian program without a set-aside designation. CDPH, as a prime contractor, has a long history of providing specialized public health services to various federal agencies, including the...
- This is a $370,094.84 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to the State of Utah Department of Environmental Quality (UDEQ) to conduct inspections of certified non-federal mammography facilities. The contract supports the Mammography Quality Standards Act (MQSA) program, which requires regular inspections to ensure compliance with quality standards. As a state government agency, UDEQ has the legal authority and experienced personnel necessary to...
- This is a $1,423,503.00 definitive, firm-fixed-price contract awarded by the Food and Drug Administration (FDA) to the Colorado Department of Public Health & Environment (CDPHE) to conduct inspections of certified non-federal mammography facilities in Colorado. The contract is not set aside for any specific type of business. The contract supports the FDA's Mammography Quality Standards Act (MQSA) program, which requires regular inspections of mammography facilities to ensure compliance...
- This is a sole-source definitive contract awarded by the Food and Drug Administration (FDA) to the Arizona Department of Health Services (ADHS) to conduct inspections of certified non-federal mammography facilities in Arizona. The contract is valued at $1,926,549.04 and has an ultimate completion date of March 29, 2028. The contract was awarded without a set-aside. The contract was awarded under the Mammography Quality Standards Act, which requires the FDA to ensure compliance with quality...
- This is a definitive, firm-fixed price contract awarded by the Food and Drug Administration (FDA) to the State of Wisconsin Department of Health Services (DHS), Operating as the Office of Legal Counsel, for the "WISCONSIN MQSA INSPECTION CONTRACT". The contract has a ceiling value of $1,720,777.81 and a completion date of January 17, 2028. This contract is not set aside. The contract supports the Mammography Quality Standards Act (MQSA) inspection program, where DHS will provide...
- This federal contract award is for the Mammography Quality Standards Act (MQSA) implementation in New York City, with a ceiling value of $3,676,553.75. The contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the City of New York's Department of Health and Mental Hygiene (Health Dept). The contract is a definitive, firm fixed-price contract, with a period of performance through March 29, 2028. It does not have a set-aside designation. The Health Dept...
This is a $2,472,203.55 firm-fixed-price definitive contract awarded by the U.S. Food and Drug Administration (FDA) to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency. The contract is for implementing the Mammography Quality Standards Act (MQSA), which provides regulatory oversight to ensure the quality and safety of mammography facilities. The contract has an ultimate completion date of March 22, 2028 and was awarded on September 20, 2022 without any set-aside designation. As a state-level agency, MDLEO has demonstrated expertise in delivering specialized regulatory and service-oriented contracts for federal agencies, in addition to its extensive portfolio of federal grants covering workforce development, vocational rehabilitation, unemployment insurance, and other critical social and economic support programs in Michigan.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Change Order | $442.8k | 9/9/25 | |
| P00006 | Supplemental Agreement for work within scope | $10.7k | 1/17/25 | |
| P00005 | Exercise an Option | $446.0k | 7/8/24 | |
| P00004 | Other Administrative Action | $0 | 3/7/24 | |
| P00003 | Supplemental Agreement for work within scope | $4.6k | 2/2/24 |